These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 21561320)
1. Effects of experimental hyperlipidaemia on the pharmacokinetics of docetaxel in rats. Lee JH; Oh JH; Lee YJ Xenobiotica; 2011 Sep; 41(9):797-804. PubMed ID: 21561320 [TBL] [Abstract][Full Text] [Related]
2. Effects of tesmilifene, a substrate of CYP3A and an inhibitor of P-glycoprotein, on the pharmacokinetics of intravenous and oral docetaxel in rats. Choi YH; Suh JH; Lee JH; Cho IH; Lee MG J Pharm Pharmacol; 2010 Aug; 62(8):1084-8. PubMed ID: 20663044 [TBL] [Abstract][Full Text] [Related]
3. Effects of cysteine on the pharmacokinetics of docetaxel in rats with protein-calorie malnutrition. Choi YH; Yoon I; Kim YG; Lee MG Xenobiotica; 2012 May; 42(5):442-55. PubMed ID: 22067009 [TBL] [Abstract][Full Text] [Related]
4. Effects of morin on the pharmacokinetics of docetaxel in rats with 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary tumors. Yang SH; Lee JH; Lee DY; Lee MG; Lyuk KC; Kim SH Arch Pharm Res; 2011 Oct; 34(10):1729-34. PubMed ID: 22076773 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of verapamil and its metabolite norverapamil in rats with hyperlipidaemia induced by poloxamer 407. Lee YS; Yoon JN; Yoon IS; Lee MG; Kang HE Xenobiotica; 2012 Aug; 42(8):766-74. PubMed ID: 22300394 [TBL] [Abstract][Full Text] [Related]
6. Effects of experimental hyperlipidemia on the pharmacokinetics of tadalafil in rats. Lee JH; Oh JH; Lee YJ J Pharm Pharm Sci; 2012; 15(4):528-37. PubMed ID: 23106956 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and tissue distribution of docetaxel by liquid chromatography-mass spectrometry: evaluation of folate receptor-targeting amphiphilic copolymer modified nanostructured lipid carrier. Zhao X; Zhao Y; Geng L; Li X; Wang X; Liu Z; Wang D; Bi K; Chen X J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Dec; 879(31):3721-7. PubMed ID: 22035980 [TBL] [Abstract][Full Text] [Related]
8. Enhanced oral bioavailability of docetaxel in rats by four consecutive days of pre-treatment with curcumin. Yan YD; Kim DH; Sung JH; Yong CS; Choi HG Int J Pharm; 2010 Oct; 399(1-2):116-20. PubMed ID: 20727390 [TBL] [Abstract][Full Text] [Related]
9. Comparative pharmacokinetic study of paclitaxel and docetaxel in streptozotocin-induced diabetic rats. Lee JH; Lee A; Oh JH; Lee YJ Biopharm Drug Dispos; 2012 Nov; 33(8):474-86. PubMed ID: 22936118 [TBL] [Abstract][Full Text] [Related]
10. Docetaxel: pharmacokinetics and tissue levels after intraperitoneal and intravenous administration in a rat model. Marchettini P; Stuart OA; Mohamed F; Yoo D; Sugarbaker PH Cancer Chemother Pharmacol; 2002 Jun; 49(6):499-503. PubMed ID: 12107555 [TBL] [Abstract][Full Text] [Related]
11. High plasma levels and effective lymphatic uptake of docetaxel in an orally available nanotransporter formulation. Nassar T; Attili-Qadri S; Harush-Frenkel O; Farber S; Lecht S; Lazarovici P; Benita S Cancer Res; 2011 Apr; 71(8):3018-28. PubMed ID: 21363913 [TBL] [Abstract][Full Text] [Related]
12. A clinical pharmacokinetic microdosing study of docetaxel with Japanese patients with cancer. Fujita K; Yoshino E; Kawara K; Maeda K; Kusuhara H; Sugiyama Y; Yokoyama T; Kaneta T; Ishida H; Sasaki Y Cancer Chemother Pharmacol; 2015 Oct; 76(4):793-801. PubMed ID: 26297058 [TBL] [Abstract][Full Text] [Related]
13. Effects of paclitaxel, docetaxel and their combinations on subcutaneous lymphomas in inbred Sprague-Dawley/Cub rats. Otová B; Václavíková R; Danielová V; Holubová J; Ehrlichová M; Horský S; Soucek P; Simek P; Gut I Eur J Pharm Sci; 2006 Dec; 29(5):442-50. PubMed ID: 17000091 [TBL] [Abstract][Full Text] [Related]
14. Preparation, characterization and pharmacokinetics of N-palmitoyl chitosan anchored docetaxel liposomes. Liang G; Jia-Bi Z; Fei X; Bin N J Pharm Pharmacol; 2007 May; 59(5):661-7. PubMed ID: 17524231 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of Amiodarone in hyperlipidemic and simulated high fat-meal rat models. Shayeganpour A; Jun AS; Brocks DR Biopharm Drug Dispos; 2005 Sep; 26(6):249-57. PubMed ID: 15968713 [TBL] [Abstract][Full Text] [Related]
16. Preclinical pharmacokinetic analysis of felotaxel (SHR110008), a novel derivative of docetaxel, in rats and its protein binding ability in vitro. Ding Y; Liu W; Lu C; Yang J; Zhu Y; Song Y; Ma Z; Yang L; Jia Y; Wen A Biomed Pharmacother; 2012 Mar; 66(2):98-102. PubMed ID: 22264880 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic advantage of intraperitoneal injection of docetaxel in the treatment for peritoneal dissemination of cancer in mice. Shimada T; Nomura M; Yokogawa K; Endo Y; Sasaki T; Miyamoto K; Yonemura Y J Pharm Pharmacol; 2005 Feb; 57(2):177-81. PubMed ID: 15720780 [TBL] [Abstract][Full Text] [Related]
18. Development of docetaxel-loaded intravenous formulation, Nanoxel-PM™ using polymer-based delivery system. Lee SW; Yun MH; Jeong SW; In CH; Kim JY; Seo MH; Pai CM; Kim SO J Control Release; 2011 Oct; 155(2):262-71. PubMed ID: 21704664 [TBL] [Abstract][Full Text] [Related]
19. Anticancer activity of stabilized palifosfamide in vivo: schedule effects, oral bioavailability, and enhanced activity with docetaxel and doxorubicin. Jones B; Komarnitsky P; Miller GT; Amedio J; Wallner BP Anticancer Drugs; 2012 Feb; 23(2):173-84. PubMed ID: 22027537 [TBL] [Abstract][Full Text] [Related]
20. Relationship of systemic exposure to unbound docetaxel and neutropenia. Baker SD; Li J; ten Tije AJ; Figg WD; Graveland W; Verweij J; Sparreboom A Clin Pharmacol Ther; 2005 Jan; 77(1):43-53. PubMed ID: 15637530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]